47m
Axios on MSNFunding for Moderna bird flu vaccine under reviewThe Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
Robert F Kennedy Jr has issued a 90-day pause for a $200million Biden-era contract with Vaxart Inc to develop a new oral ...
A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...
Moderna's reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...
The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...
U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...
Last year, the administration of former President Joe Biden allocated more than $800 million to combat bird flu in livestock.
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...
Allspring Global Investments Holdings LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 12.2% in the fourth quarter, Holdings Channel reports. The firm owned 15,368 shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results